BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17018259)

  • 41. Akt signaling and cancer: surviving but not moving on.
    Toker A; Yoeli-Lerner M
    Cancer Res; 2006 Apr; 66(8):3963-6. PubMed ID: 16618711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The phosphoinositide 3-kinase pathway and cancer.
    Stokoe D
    Expert Rev Mol Med; 2005 Jun; 7(10):1-22. PubMed ID: 15938760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blockade of Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2/neu.
    Yan YY; Zheng LS; Zhang X; Chen LK; Singh S; Wang F; Zhang JY; Liang YJ; Dai CL; Gu LQ; Zeng MS; Talele TT; Chen ZS; Fu LW
    Mol Pharm; 2011 Oct; 8(5):1687-97. PubMed ID: 21812426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A FRET-based microplate assay for human protein kinase CK2, a target in neoplastic disease.
    Gratz A; Götz C; Jose J
    J Enzyme Inhib Med Chem; 2010 Apr; 25(2):234-9. PubMed ID: 19874207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Validation of protein kinase CK2 as oncological target.
    Seeber S; Issinger OG; Holm T; Kristensen LP; Guerra B
    Apoptosis; 2005 Aug; 10(4):875-85. PubMed ID: 16133877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neisseria gonorrhoeae PLD directly interacts with Akt kinase upon infection of primary, human, cervical epithelial cells.
    Edwards JL; Apicella MA
    Cell Microbiol; 2006 Aug; 8(8):1253-71. PubMed ID: 16882030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Akt of translational control.
    Ruggero D; Sonenberg N
    Oncogene; 2005 Nov; 24(50):7426-34. PubMed ID: 16288289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel inhibitors of the PI3K family.
    Carnero A
    Expert Opin Investig Drugs; 2009 Sep; 18(9):1265-77. PubMed ID: 19589091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross-talk between the CK2 and AKT signaling pathways in cancer.
    Ruzzene M; Bertacchini J; Toker A; Marmiroli S
    Adv Biol Regul; 2017 May; 64():1-8. PubMed ID: 28373060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival-signaling pathway as a promising target for cancer chemotherapy.
    Fujita N; Tsuruo T
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S24-8. PubMed ID: 12819931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emodin induces cytotoxic effect in human breast carcinoma MCF-7 cell through modulating the expression of apoptosis-related genes.
    Li WY; Chan RY; Yu PH; Chan SW
    Pharm Biol; 2013 Sep; 51(9):1175-81. PubMed ID: 23763280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Src/PI3K/Akt signal pathway may play a key role in decreased drug efficacy in obesity-associated cancer.
    Chen J
    J Cell Biochem; 2010 May; 110(2):279-80. PubMed ID: 20432241
    [No Abstract]   [Full Text] [Related]  

  • 53. Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumor necrosis factor-alpha-induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK-N-SH cells.
    Kim KY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Shin YW; Hong KW
    J Pharmacol Exp Ther; 2004 Jan; 308(1):97-104. PubMed ID: 14569058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antitumor effects of emodin in CACO-2 human colon carcinoma cells are mediated via apoptosis, cell cycle arrest and downregulation of PI3K/AKT signalling pathway.
    Ma Q; Ding Y; Wu Z; Li Y
    J BUON; 2018; 23(3):587-591. PubMed ID: 30003723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of protein kinase CK2 in cyclosporine-induced nephropathy in rats.
    Son YK; Lee SM; An WS; Kim KH; Rha SH; Rho JH; Kim SE
    Transplant Proc; 2013 Mar; 45(2):756-62. PubMed ID: 23498817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel curcumin- and emodin-related compounds identified by in silico 2D/3D conformer screening induce apoptosis in tumor cells.
    Füllbeck M; Huang X; Dumdey R; Frommel C; Dubiel W; Preissner R
    BMC Cancer; 2005 Aug; 5():97. PubMed ID: 16083495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RNAi-based screening of the human kinome identifies Akt-cooperating kinases: a new approach to designing efficacious multitargeted kinase inhibitors.
    Morgan-Lappe S; Woods KW; Li Q; Anderson MG; Schurdak ME; Luo Y; Giranda VL; Fesik SW; Leverson JD
    Oncogene; 2006 Mar; 25(9):1340-8. PubMed ID: 16247451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein kinase CK2 impairs spatial memory formation through differential cross talk with PI-3 kinase signaling: activation of Akt and inactivation of SGK1.
    Chao CC; Ma YL; Lee EH
    J Neurosci; 2007 Jun; 27(23):6243-8. PubMed ID: 17553997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene expression alteration during redox-dependent enhancement of arsenic cytotoxicity by emodin in HeLa cells.
    Wang XJ; Yang J; Cang H; Zou YQ; Yi J
    Cell Res; 2005 Jul; 15(7):511-22. PubMed ID: 16045814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extracellular phosphorylation of C9 by protein kinase CK2 regulates complement-mediated lysis.
    Bohana-Kashtan O; Pinna LA; Fishelson Z
    Eur J Immunol; 2005 Jun; 35(6):1939-48. PubMed ID: 15902683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.